Mandate

Vinge advises on equity line and rights issue guarantee to Karo Bio

October 27, 2010

Azimuth Opportunity, Inc and Karo Bio AB (publ) (NASDAQ OMX Stockholm) have entered an agreement regarding a so-called Equity Credit Facility, whereby Azimuth has undertaken to subscribe for new shares in Karo Bio on Karo Bio’s request and as set out in the terms of the facility, of up to USD 35 million. In addition, Azimuth guarantees part of Karo Bio’s rights issue of approx. SEK 300 million. The Facility and the rights issue are subject to approval by the general meeting of Karo Bio.

Vinge advises Azimuth. Vinge’s team is headed by capital markets partner Erik Sjöman.

Related

Vinge advises HAKI Safety in connection with its divestment of Landqvist Mekaniska Verkstad to Opima

Landqvist Mekaniska Verkstad is a mechanical engineering company specialising in metal machining and contract manufacturing, primarily serving Swedish industries. In 2024, it had annual sales of approximately SEK 78 M and an operating profit of SEK 9 M. The divestment is a step in HAKI Safety's change of strategy from a conglomerate to the current industry group with a focus on safety products and solutions that aim to create safe conditions for everyone working in challenging environments. Having completed this divestment, HAKI Safey now consists entirely of operations within work zone safety, scaffolding systems, and digital and technical solutions.
May 07, 2025

Vinge advises Main Capital and Pointsharp on the acquisition of Vemendo

Vinge has advised Pointsharp International AB, an identity and access management software provider, on its acquisition of Vemendo AB (“Vemendo”). The strategic acquisition complements Pointsharp well and is in line with the company's growth strategy in the European identity and access management market.
May 07, 2025

Vinge advises Schibsted Tillväxtmedier in connection with its divestment of Prisjakt

Schibsted Tillväxtmedier has entered into an agreement for the sale of Prisjakt to eEquity. The consideration is expected to amount to around SEK 500 million. Schibsted has owned Prisjakt for approximately 20 years and the divestment is made as part of Schibsted’s ongoing streamlining of its organisation and portfolio.
May 06, 2025